Caris Life Sciences (NASDAQ:CAI) Insider Luke Thomas Power Sells 62,250 Shares of Stock

Caris Life Sciences, Inc. (NASDAQ:CAI) insider Luke Thomas Power sold 62,250 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $26.58, for a total transaction of $1,654,605.00. Following the transaction, the insider owned 99,571 shares in the company, valued at approximately $2,646,597.18. This trade represents a 38.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Caris Life Sciences Price Performance

Caris Life Sciences stock opened at $26.76 on Friday. Caris Life Sciences, Inc. has a 1-year low of $22.86 and a 1-year high of $42.50.

Analyst Ratings Changes

A number of brokerages have recently commented on CAI. Wall Street Zen lowered Caris Life Sciences from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Canaccord Genuity Group assumed coverage on Caris Life Sciences in a research report on Tuesday, December 2nd. They set a “hold” rating and a $28.00 target price for the company. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Caris Life Sciences in a research report on Wednesday. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $28.00.

About Caris Life Sciences

We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets.